Literature DB >> 22490317

Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users.

Neal L Benowitz1, Caroline C Renner, Anne P Lanier, Rachel F Tyndale, Dorothy K Hatsukami, Bruce Lindgren, Irina Stepanov, Clifford H Watson, Connie S Sosnoff, Peyton Jacob.   

Abstract

BACKGROUND: The prevalence of tobacco use, both cigarette smoking and smokeless, including iqmik (homemade smokeless tobacco prepared with dried tobacco leaves mixed with alkaline ash), and of tobacco-related cancer is high in Alaskan Native people (AN). To investigate possible mechanisms of increased cancer risk we studied levels of nicotine and tobacco-specific nitrosamines (TSNA) in tobacco products and biomarkers of tobacco toxicant exposure in Southwestern AN people.
METHODS: Participants included 163 cigarette smokers, 76 commercial smokeless tobacco, 20 iqmik, 31 dual cigarette smokers and smokeless tobacco, and 110 nontobacco users. Tobacco use history, samples of tobacco products used, and blood and urine samples were collected.
RESULTS: Nicotine concentrations were highest in cigarette tobacco and TSNAs highest in commercial smokeless tobacco products. The AN participants smoked on average 7.8 cigarettes per day. Nicotine exposure, assessed by several biomarker measures, was highest in iqmik users, and similar in smokeless tobacco and cigarette smokers. TSNA exposure was highest in smokeless tobacco users, and polycyclic aromatic hydrocarbon exposure was highest in cigarette smokers.
CONCLUSIONS: Despite smoking fewer cigarettes per day, AN cigarette smokers had similar daily intake of nicotine compared to the general U.S. population. Nicotine exposure was greatest from iqmik, likely related to its high pH due to preparation with ash, suggesting high addiction potential compared to other smokeless tobacco products. TSNA exposure was much higher with smokeless tobacco than other product use, possibly contributing to the high rates of oral cancer. IMPACT: Our data contribute to an understanding of the high addiction risk of iqmik use and of the cancer-causing potential of various forms of tobacco use among AN people.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490317      PMCID: PMC3444141          DOI: 10.1158/1055-9965.EPI-11-1178

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  30 in total

1.  Biochemical verification of tobacco use and cessation.

Authors: 
Journal:  Nicotine Tob Res       Date:  2002-05       Impact factor: 4.244

2.  Time course of nicotine and cotinine incorporation into samples of nonsmokers' beard hair following a single dose of nicotine polacrilex.

Authors:  John T Bernert; Joseph R Alexander; Connie S Sosnoff; James E McGuffey
Journal:  J Anal Toxicol       Date:  2011-01       Impact factor: 3.367

Review 3.  Cotinine as a biomarker of environmental tobacco smoke exposure.

Authors:  N L Benowitz
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

4.  Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.

Authors:  Peyton Jacob; Lisa Yu; Minjiang Duan; Lita Ramos; Olivia Yturralde; Neal L Benowitz
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-21       Impact factor: 3.205

5.  Measuring dependence in smokeless tobacco users.

Authors:  R G Boyle; J Jensen; D K Hatsukami; H H Severson
Journal:  Addict Behav       Date:  1995 Jul-Aug       Impact factor: 3.913

6.  Racial differences in the relationship between number of cigarettes smoked and nicotine and carcinogen exposure.

Authors:  Neal L Benowitz; Katherine M Dains; Delia Dempsey; Margaret Wilson; Peyton Jacob
Journal:  Nicotine Tob Res       Date:  2011-05-05       Impact factor: 4.244

7.  Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men.

Authors:  A Wennmalm; G Benthin; E F Granström; L Persson; A S Petersson; S Winell
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

8.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

Review 9.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer.

Authors:  Stephen S Hecht
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

10.  Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  R S Caraballo; G A Giovino; T F Pechacek; P D Mowery; P A Richter; W J Strauss; D J Sharp; M P Eriksen; J L Pirkle; K R Maurer
Journal:  JAMA       Date:  1998-07-08       Impact factor: 56.272

View more
  19 in total

1.  Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Authors:  Baoyun Xia; Benjamin C Blount; Tonya Guillot; Christina Brosius; Yao Li; Dana M Van Bemmel; Heather L Kimmel; Cindy M Chang; Nicolette Borek; Kathryn C Edwards; Charlie Lawrence; Andrew Hyland; Maciej L Goniewicz; Brittany N Pine; Yang Xia; John T Bernert; B Rey De Castro; John Lee; Justin L Brown; Stephen Arnstein; Diane Choi; Erin L Wade; Dorothy Hatsukami; Gladys Ervies; Angel Cobos; Keegan Nicodemus; Dana Freeman; Stephen S Hecht; Kevin Conway; Lanqing Wang
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

2.  Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study.

Authors:  Christi A Patten; Kathryn R Koller; Christie A Flanagan; Vanessa Y Hiratsuka; Christine A Hughes; Abbie W Wolfe; Paul A Decker; Kristin Fruth; Tabetha A Brockman; Molly Korpela; Diana Gamez; Carrie Bronars; Neil J Murphy; Dorothy Hatsukami; Neal L Benowitz; Timothy K Thomas
Journal:  Patient Educ Couns       Date:  2018-10-12

3.  Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.

Authors:  Binnian Wei; Benjamin C Blount; Baoyun Xia; Lanqing Wang
Journal:  J Expo Sci Environ Epidemiol       Date:  2015-01-07       Impact factor: 5.563

4.  Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation.

Authors:  Andy Z X Zhu; Matthew J Binnington; Caroline C Renner; Anne P Lanier; Dorothy K Hatsukami; Irina Stepanov; Clifford H Watson; Connie S Sosnoff; Neal L Benowitz; Rachel F Tyndale
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

5.  Association between iq'mik smokeless tobacco use and cardiometabolic risk profile among Yup'ik Alaska Native people.

Authors:  Tove K Ryman; Bert B Boyer; Scarlett E Hopkins; Jacques Philip; Beti Thompson; Shirley A A Beresford; Kenneth E Thummel; Melissa A Austin
Journal:  Ethn Health       Date:  2017-01-24       Impact factor: 2.772

6.  The Healthy Pregnancies Project: Study protocol and baseline characteristics for a cluster-randomized controlled trial of a community intervention to reduce tobacco use among Alaska Native pregnant women.

Authors:  Christi A Patten; Harry A Lando; Chris A Desnoyers; Yvette Barrows; Joseph Klejka; Paul A Decker; Christine A Hughes; Martha J Bock; Rahnia Boyer; Kenneth Resnicow; Linda Burhansstipanov
Journal:  Contemp Clin Trials       Date:  2019-01-28       Impact factor: 2.226

7.  Fetal Exposure to Carcinogens With Tobacco Use in Pregnancy: Phase 1 MAW Study Findings.

Authors:  Christie A Flanagan; Kathryn R Koller; Abbie W Wolfe; Timothy K Thomas; Neal L Benowitz; Caroline C Renner; Christine Hughes; Dorothy K Hatsukami; Carrie Bronars; Neil J Murphy; Gretchen Day; Paul A Decker; Christi A Patten
Journal:  Nicotine Tob Res       Date:  2016-05-17       Impact factor: 4.244

8.  The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex.

Authors:  Andy Z X Zhu; Caroline C Renner; Dorothy K Hatsukami; Gary E Swan; Caryn Lerman; Neal L Benowitz; Rachel F Tyndale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-31       Impact factor: 4.254

9.  CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users.

Authors:  Andy Z X Zhu; Caroline C Renner; Dorothy K Hatsukami; Neal L Benowitz; Rachel F Tyndale
Journal:  Addiction       Date:  2013-07-05       Impact factor: 6.526

10.  The Healing and Empowering Alaskan Lives Toward Healthy-Hearts (HEALTHH) Project: Study protocol for a randomized controlled trial of an intervention for tobacco use and other cardiovascular risk behaviors for Alaska Native People.

Authors:  Judith J Prochaska; Anna Epperson; Jordan Skan; Marily Oppezzo; Paul Barnett; Kevin Delucchi; Matthew Schnellbaecher; Neal L Benowitz
Journal:  Contemp Clin Trials       Date:  2018-06-02       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.